Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration

Blood

Volumn 119, Issue 23, 2012, Pages 5429-5437

  Nakamura Ishizu, Ayako ^a   Okuno, Yuji ^b   Omatsu, Yoshiki ^c,d   Okabe, Keisuke ^a,b   Morimoto, Junko ^e   Uede, Toshimitsu ^e   Nagasawa, Takashi ^c,d   Suda, Toshio ^a   Kubota, Yoshiaki ^a,b  

^a KEIO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHA5 INTEGRIN; ALPHA7 INTEGRIN; ALPHA9 INTEGRIN; BETA1 INTEGRIN; BETA3 INTEGRIN; BETA6 INTEGRIN; CD51 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN E; CYCLIN G1; FLUOROURACIL; MESSENGER RNA; MYC PROTEIN; TENASCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL FUNCTION; CELL PROLIFERATION; CELL REGENERATION; CHIMERA; CONVALESCENCE; DOWN REGULATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; IN VIVO STUDY; LETHALITY; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEADY STATE; STEM CELL NICHE; STROMA CELL; UPREGULATION;

EID: 84862531002     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-393645     Document Type: Article

References (42)

1. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978;4(1-2):7-25. (Pubitemid 8376317)
2. Moore KA, Lemischka IR. Stem cells and their niches. Science. 2006;311(5769):1880-1885.
3. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006;6(2):93-106.
4. Taichman RS. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood. 2005;105(7):2631-2639. (Pubitemid 40446251)
5. Arai F, Hirao A, Ohmura M, et al. Tie2 / angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118(2):149-161. (Pubitemid 38962572)
6. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425(6960):836-841. (Pubitemid 37351467)
7. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425(6960):841-846. (Pubitemid 37351468)
8. Kiel MJ, Yilmaz OH, Iwashita T, et al. Slam family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121(7):1109-1121. (Pubitemid 40884400)
9. Kobayashi H, Butler JM, O'Donnell R, et al. Angiocrine factors from akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol. 2010;12(11):1046-1056.
10. Chow A, Lucas D, Hidalgo A, et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med. 2011;208(2):261-271.
11. Jaiswal S, Jamieson CH, Pang WW, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138(2):271-285.
12. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25(6):977-988. (Pubitemid 44894948)
13. Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829-834.
14. Nilsson SK, Debatis ME, Dooner MS, et al. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ. J Histochem Cytochem. 1998;46(3):371-377. (Pubitemid 28117387)
15. Klein G, Beck S, Müller CA. Tenascin is a cytoadhesive extracellular matrix component of the human hematopoietic microenvironment. J Cell Biol. 1993;123(4):1027-1035. (Pubitemid 23333588)
16. Kubota Y, Takubo K, Suda T. Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche. Biochem Biophys Res Commun. 2008;366(2):335-339. (Pubitemid 50016265)
17. Zuckerman KS, Wicha MS. Extracellular matrix production by the adherent cells of long-term murine bone marrow cultures. Blood. 1983;61(3):540-547. (Pubitemid 13148155)
18. Hsia HC, Schwarzbauer JE. Meet the tenascins: multifunctional and mysterious. J Biol Chem. 2005;280(29):26641-26644. (Pubitemid 41040694)
19. Gueders MM, Hirst SJ, Quesada-Calvo F, et al. Matrix metalloproteinase-19 deficiency promotes tenascin-C accumulation and allergen-induced airway inflammation. Am J Respir Cell Mol Biol. 2010;43(3):286-295.
20. Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M. Corneal wound healing in tenascin knockout mouse. Invest Ophthal Vis Sci. 1999;40(6):1071- 1080. (Pubitemid 29211444)
21. Koyama Y, Kusubata M, Yoshiki A, et al. Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse. J Invest Dermatol. 1998;111(6):930-935. (Pubitemid 29115156)
22. Soini Y, Kamel D, Apaja-Sarkkinen M, Virtanen I, Lehto VP. Tenascin immunoreactivity in normal and pathological bone marrow. J Clin Pathol. 1993;46(3):218-221. (Pubitemid 23098619)
23. Jones PL, Jones FS. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol. 2000;19(7):581-596.
24. Ohta M, Sakai T, Saga Y, Aizawa S, Saito M. Suppression of hematopoietic activity in tenascin-C-deficient mice. Blood. 1998;91(11):4074-4083. (Pubitemid 28261968)
25. Schreiber TD, Steinl C, Essl M, et al. The integrin alpha9beta1 on hematopoietic stem and progenitor cells: involvement in cell adhesion, proliferation and differentiation. Haematologica. 2009;94(11):1493-1501.
26. Nakao N, Hiraiwa N, Yoshiki A, Ike F, Kusakabe M. Tenascin-C promotes healing of habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Am J Pathol. 1998;152(5):1237-1245. (Pubitemid 28221876)
27. Kanayama M, Kurotaki D, Morimoto J, et al. Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J Immunol. 2009;182(12):8015-8025.
28. Kubota Y, Takubo K, Shimizu T, et al. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med. 2009;206(5):1089-1102.
29. Morikawa S, Mabuchi Y, Kubota Y, et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med. 2009;206(11):2483-2496.
30. Omatsu Y, Sugiyama T, Kohara H, et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity. 2010;33(3):387-399.
31. Yokosaki Y, Monis H, Chen J, Sheppard D. Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. roles of the beta subunit extracellular and cytoplasmic domains. J Biol Chem. 1996;271(39):24144-24150.
32. Andrews MR, Czvitkovich S, Dassie E, et al. Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J Neurosci. 2009;29(17):5546-5557.
33. Grassinger J, Haylock DN, Storan MJ, et al. Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood. 2009;114(1):49-59.
34. Haylock DN, Nilsson SK. Osteopontin: a bridge between bone and blood. Br J Haematol. 2006;134(5):467-474. (Pubitemid 44141712)
35. Adolfsson J, Borge OJ, Bryder D, et al. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity. 2001;15(4):659-669. (Pubitemid 33016450)
36. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999;94(8):2548-2554. (Pubitemid 29477281)
37. Orend G, Huang W, Olayioye MA, Hynes NE, Chiquet-Ehrismann R. Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4. Oncogene. 2003;22(25):3917-3926. (Pubitemid 36819665)
38. Yokosaki Y, Matsuura N, Higashiyama S, et al. Identification of the ligand binding site for the integrin alpha 9beta 1 in the third fibronectin type III repeat of tenascin-C. J Biol Chem. 1998;273(19):11423-11428. (Pubitemid 28272033)
39. Liao YF, Gotwals PJ, Koteliansky VE, Sheppard D, Van De Water L. The eiiia segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem. 2002;277(17):14467-14474. (Pubitemid 34952511)
40. Yokosaki Y, Palmer EL, Prieto AL, et al. The integrin alpha 9 beta 1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin. J Biol Chem. 1994;269(43):26691-26696.
41. Wirl G, Hermann M, Ekblom P, Fässler R. Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation. J Cell Sci. 1995;108(Pt 6):2445-2456.
42. Yoshida T, Yoshimura E, Numata H, Sakakura Y, Sakakura T. Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Archiv. 1999;435(5):496-500.